Charles Conroy, Nucleus RadioPharma CEO

Mayo Clin­ic-backed Nu­cle­us Ra­dio­Phar­ma rais­es $56M in Se­ries A to boost CD­MO ser­vices

Nu­cle­us Ra­dio­Phar­ma is mak­ing a splash with an over­sub­scribed $56 mil­lion Se­ries A to prop up the CD­MO’s man­u­fac­tur­ing ca­pac­i­ty, with a Rochester, MN site …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.